MicroBiome Therapeutics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

MicroBiome Therapeutics General Information

Description

Developer of microbiome modulators intended for metabolic diseases that aim to improve health status by altering microbial populations and their environment in the GI tract. The company's microbiome modulators includes fermentable fiber and polyphenol antioxidants in a patent-pending blendare designed to augment the growth of certain bacterial strains and discourage the growth of others, enabling nurture and nourish beneficial microorganisms in the lower gut.

Contact Information

Website
www.mbiome.com
Formerly Known As
NuMe Health
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Gertrude Pfost
  • 5500 Prytania Street, Suite 530
  • New Orleans, LA 70115
  • United States
+1 (609)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Gertrude Pfost
  • 5500 Prytania Street, Suite 530
  • New Orleans, LA 70115
  • United States
+1 (609)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroBiome Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 03-Aug-2020 Completed Out of Business
7. Later Stage VC (Series B) 08-Sep-2017 Completed Generating Revenue
6. Later Stage VC 18-Jun-2015 Completed Generating Revenue
5. Early Stage VC (Series A) 30-Nov-2013 Completed Generating Revenue
4. Early Stage VC (Series A) 02-May-2012 Completed Startup
3. Early Stage VC (Series A1) 26-Jul-2011 Completed Startup
2. Accelerator/Incubator 01-Jan-2010 Completed Startup
1. Accelerator/Incubator Completed Startup
To view MicroBiome Therapeutics’s complete valuation and funding history, request access »

MicroBiome Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbiome modulators intended for metabolic diseases that aim to improve health status by altering microbi
Biotechnology
New Orleans, LA
3 As of 2017

Cambridge, MA
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MicroBiome Therapeutics Competitors (30)

One of MicroBiome Therapeutics’s 30 competitors is Vedanta Biosciences, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
Eligo Bioscience Venture Capital-Backed Paris, France
Enterome Venture Capital-Backed Paris, France
Intralytix Corporate Backed or Acquired Baltimore, MD
PEP-Therapy Venture Capital-Backed Evry Cedex, France
You’re viewing 5 of 30 competitors. Get the full list »

MicroBiome Therapeutics Patents

MicroBiome Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015200842-A1 Composition comprising metformin and a microbiome modulator Inactive 26-Jun-2014
CA-2935254-A1 Activated soy pod fiber Inactive 20-Feb-2014
EP-3107535-A1 Activated soy pod fiber Inactive 20-Feb-2014
WO-2015127314-A1 Activated soy pod fiber Inactive 20-Feb-2014
CA-2902248-A1 Activated soy pod fiber Inactive 15-Mar-2013 A61K31/352
To view MicroBiome Therapeutics’s complete patent history, request access »

MicroBiome Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MicroBiome Therapeutics FAQs

  • When was MicroBiome Therapeutics founded?

    MicroBiome Therapeutics was founded in 2009.

  • Where is MicroBiome Therapeutics headquartered?

    MicroBiome Therapeutics is headquartered in New Orleans, LA.

  • What is the size of MicroBiome Therapeutics?

    MicroBiome Therapeutics has 3 total employees.

  • What industry is MicroBiome Therapeutics in?

    MicroBiome Therapeutics’s primary industry is Biotechnology.

  • Is MicroBiome Therapeutics a private or public company?

    MicroBiome Therapeutics is a Private company.

  • What is MicroBiome Therapeutics’s current revenue?

    The current revenue for MicroBiome Therapeutics is .

  • How much funding has MicroBiome Therapeutics raised over time?

    MicroBiome Therapeutics has raised $5.42M.

  • Who are MicroBiome Therapeutics’s competitors?

    Vedanta Biosciences, Eligo Bioscience, Enterome, Intralytix, and PEP-Therapy are some of the 30 competitors of MicroBiome Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process